10 Degree C Static Storage in Heart Transplantation
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- John Trahanas
- Study ID
- NCT07818941
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Heart Failure
- Heart Transplant
- Transplant, Failure, Heart
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 10 degree C Static Storage Cooler — DEVICEThe X°Port HPS (Heart Preservation System) is a portable, insulated device designed to maintain donor hearts at an optimal preservation temperature (4°C to 10°C) during static cold storage and transport. The system uses pre-conditioned cooling packs arranged in both the base and lid compartments to create a sub-normothermic thermal environment.
Study Details
The goal of this clinical trial is to conduct a feasibility investigation evaluating the preliminary safety and effectiveness of using the X°Port Heart Preservation System (XHPS) for 10°C preservation in clinical heart transplantation. Participants will: * undergo a standard heart transplant, with a donor heart preserved and transported at 10°C using the XHPS. * have data collected at key timepoints related to their recovery in the ICU and hospital * return after discharge for standard follow-up appointments, with capture of standard data collected
Key Dates
- First listed
- Sep 14, 2026
- Start date
- Oct 31, 2026
- Status verified
- Sep 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Subjects Requiring Heart a TransplantIntervention: 10° C Heart Preservation
Primary Outcome Measure
Evidence of severe primary graft dysfunction (PGD) [ Time Frame: 24 hours post-transplant ]
Central Contacts
- John Trahanas, MD615-343-9195
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | John Trahanas, MD John Trahanas, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Nashville, TN
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Global Utilization And Registry Database for Improved heArt preservatioNEnrolling By Invitation · Paragonix Technologies · Stanford, California
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Palo Alto, California